290 related articles for article (PubMed ID: 30282750)
1. B Cell-Intrinsic STING Signaling Triggers Cell Activation, Synergizes with B Cell Receptor Signals, and Promotes Antibody Responses.
Walker MM; Crute BW; Cambier JC; Getahun A
J Immunol; 2018 Nov; 201(9):2641-2653. PubMed ID: 30282750
[TBL] [Abstract][Full Text] [Related]
2. Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG.
Yildiz S; Alpdundar E; Gungor B; Kahraman T; Bayyurt B; Gursel I; Gursel M
Eur J Immunol; 2015 Apr; 45(4):1170-9. PubMed ID: 25581346
[TBL] [Abstract][Full Text] [Related]
3. STING is a direct innate immune sensor of cyclic di-GMP.
Burdette DL; Monroe KM; Sotelo-Troha K; Iwig JS; Eckert B; Hyodo M; Hayakawa Y; Vance RE
Nature; 2011 Sep; 478(7370):515-8. PubMed ID: 21947006
[TBL] [Abstract][Full Text] [Related]
4.
Guimarães ES; Gomes MTR; Campos PC; Mansur DS; Dos Santos AA; Harms J; Splitter G; Smith JA; Barber GN; Oliveira SC
J Immunol; 2019 May; 202(9):2671-2681. PubMed ID: 30894428
[No Abstract] [Full Text] [Related]
5. MPYS/STING-mediated TNF-α, not type I IFN, is essential for the mucosal adjuvant activity of (3'-5')-cyclic-di-guanosine-monophosphate in vivo.
Blaauboer SM; Gabrielle VD; Jin L
J Immunol; 2014 Jan; 192(1):492-502. PubMed ID: 24307739
[TBL] [Abstract][Full Text] [Related]
6. Detection of Cyclic Dinucleotides by STING.
Du XX; Su XD
Methods Mol Biol; 2017; 1657():59-69. PubMed ID: 28889286
[TBL] [Abstract][Full Text] [Related]
7. Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins.
Martin TL; Jee J; Kim E; Steiner HE; Cormet-Boyaka E; Boyaka PN
Vaccine; 2017 Apr; 35(18):2511-2519. PubMed ID: 28343781
[TBL] [Abstract][Full Text] [Related]
8. The role of cGAMP via the STING pathway in modulating germinal center responses and CD4 T cell differentiation.
Yoon M; Choi Y; Wi T; Choi YS; Choi J
Front Immunol; 2024; 15():1340001. PubMed ID: 38680492
[TBL] [Abstract][Full Text] [Related]
9. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
Woo SR; Fuertes MB; Corrales L; Spranger S; Furdyna MJ; Leung MY; Duggan R; Wang Y; Barber GN; Fitzgerald KA; Alegre ML; Gajewski TF
Immunity; 2014 Nov; 41(5):830-42. PubMed ID: 25517615
[TBL] [Abstract][Full Text] [Related]
10. Tuning the Innate Immune Response to Cyclic Dinucleotides by Using Atomic Mutagenesis.
Li Y; Fin A; Rovira AR; Su Y; Dippel AB; Valderrama JA; Riestra AM; Nizet V; Hammond MC; Tor Y
Chembiochem; 2020 Sep; 21(18):2595-2598. PubMed ID: 32346955
[TBL] [Abstract][Full Text] [Related]
11. STING pathway stimulation results in a differentially activated innate immune phenotype associated with low nitric oxide and enhanced antibody titers in young and aged mice.
Darling RJ; Senapati S; Kelly SM; Kohut ML; Narasimhan B; Wannemuehler MJ
Vaccine; 2019 May; 37(20):2721-2730. PubMed ID: 30987850
[TBL] [Abstract][Full Text] [Related]
12. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
[TBL] [Abstract][Full Text] [Related]
13. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling.
Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH
J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854
[TBL] [Abstract][Full Text] [Related]
14. STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice.
Skouboe MK; Knudsen A; Reinert LS; Boularan C; Lioux T; Perouzel E; Thomsen MK; Paludan SR
PLoS Pathog; 2018 Apr; 14(4):e1006976. PubMed ID: 29608601
[TBL] [Abstract][Full Text] [Related]
15. STING-dependent cytosolic DNA sensing pathways.
Barber GN
Trends Immunol; 2014 Feb; 35(2):88-93. PubMed ID: 24309426
[TBL] [Abstract][Full Text] [Related]
16. STING activation in cancer immunotherapy.
Su T; Zhang Y; Valerie K; Wang XY; Lin S; Zhu G
Theranostics; 2019; 9(25):7759-7771. PubMed ID: 31695799
[TBL] [Abstract][Full Text] [Related]
17. CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.
Haas KM; Johnson KL; Phipps JP; Do C
J Immunol; 2018 Mar; 200(5):1671-1681. PubMed ID: 29374074
[TBL] [Abstract][Full Text] [Related]
18. Selective Loss of Responsiveness to Exogenous but Not Endogenous Cyclic-Dinucleotides in Mice Expressing STING-R231H.
Walker MM; Kim S; Crisler WJ; Nguyen K; Lenz LL; Cambier JC; Getahun A
Front Immunol; 2020; 11():238. PubMed ID: 32153571
[TBL] [Abstract][Full Text] [Related]
19. Type I IFN Receptor Signaling on B Cells Promotes Antibody Responses to Polysaccharide Antigens.
Spurrier MA; Jennings-Gee JE; Haas KM
J Immunol; 2023 Jan; 210(2):148-157. PubMed ID: 36458995
[TBL] [Abstract][Full Text] [Related]
20. STING regulates BCR signaling in normal and malignant B cells.
Tang CA; Lee AC; Chang S; Xu Q; Shao A; Lo Y; Spalek WT; Pinilla-Ibarz JA; Del Valle JR; Hu CA
Cell Mol Immunol; 2021 Apr; 18(4):1016-1031. PubMed ID: 32999453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
